asbe
- Pharmaceutical company Endo (OTCQX:NDOI) said that Blaise Coleman will depart the company as President & CEO and from the Board of Directors, effective on August 29, 2024.
- Scott Hirsch has been appointed to serve as interim CEO in the transition period while the search is ongoing.
- The Board of Directors has initiated a search for the next CEO and has retained Spencer Stuart, an executive search firm, to assist in the search process.
- Mr. Hirsch joined the Endo (OTCQX:NDOI) Board of Directors in April 2024. He has over 20 years of experience in healthcare, investment management, and financial services and was formerly the CEO of Solta Medical.
